Literature DB >> 26864668

Coronary anatomy as related to bicuspid aortic valve morphology.

Wilke M C Koenraadt1, George Tokmaji2, Marco C DeRuiter3, Hubert W Vliegen1, Arthur J H A Scholte1, Hans Marc J Siebelink1, Adriana C Gittenberger-de Groot3, Michiel A de Graaf1, Ron Wolterbeek4, Barbara J Mulder2, Berto J Bouma2, Martin J Schalij1, Monique R M Jongbloed5.   

Abstract

OBJECTIVE: Variable coronary anatomy has been described in patients with bicuspid aortic valves (BAVs). This was never specified to BAV morphology, and prognostic relevance of coronary vessel dominance in this patient group is unclear. The purpose of this study was to evaluate valve morphology in relation to coronary artery anatomy and outcome in patients with isolated BAV and with associated aortic coarctation (CoA).
METHODS: Coronary anatomy was evaluated in 186 patients with BAV (141 men (79%), 51±14 years) by CT and invasive coronary angiography. Correlation of coronary anatomy was made with BAV morphology and coronary events.
RESULTS: Strictly bicuspid valves (without raphe) with left-right cusp fusion (type 1B) had more left dominant coronary systems compared with BAVs with left-right cusp fusion with a raphe (type 1A) (48% vs. 26%, p=0.047) and showed more separate ostia (28% vs. 9%, p=0.016). Type 1B BAVs had more coronary artery disease than patients with type 1A BAV (36% vs. 19%, p=0.047). More left dominance was seen in BAV patients with CoA than in patients without (65% vs. 24%, p<0.05).
CONCLUSIONS: The incidence of a left dominant coronary artery system and separate ostia was significantly related to BAVs with left-right fusion without a raphe (type 1B). These patients more often had significant coronary artery disease. In patients with BAV and CoA, left dominancy is more common. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Year:  2016        PMID: 26864668     DOI: 10.1136/heartjnl-2015-308629

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  6 in total

1.  Coronary Artery Origins Pattern in Pediatric Patients with Right-Left Fusion Bicuspid Aortic Valve.

Authors:  Daniel N Beauchamp; Claudio Ramaciotti; Paul Brown; Poonam P Thankavel
Journal:  Pediatr Cardiol       Date:  2022-02-20       Impact factor: 1.838

Review 2.  Valvular heart disease in congenital heart disease: a narrative review.

Authors:  Joshua M Saef; Joanna Ghobrial
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

3.  Weakly supervised classification of aortic valve malformations using unlabeled cardiac MRI sequences.

Authors:  Jason A Fries; Paroma Varma; Vincent S Chen; Ke Xiao; Heliodoro Tejeda; Priyanka Saha; Jared Dunnmon; Henry Chubb; Shiraz Maskatia; Madalina Fiterau; Scott Delp; Euan Ashley; Christopher Ré; James R Priest
Journal:  Nat Commun       Date:  2019-07-15       Impact factor: 14.919

4.  Identifying Patients with Bicuspid Aortic Valve Disease in UK Primary Care: A Case-Control Study and Prediction Model.

Authors:  William Evans; Ralph Kwame Akyea; Stephen Weng; Joe Kai; Nadeem Qureshi
Journal:  J Pers Med       Date:  2022-08-05

5.  Concomitant cardiovascular malformations in isolated bicuspid aortic valve disease: a retrospective cross-sectional study and meta-analysis.

Authors:  Katalin Szöcs; Betül Toprak; Gerhard Schön; Meike Rybczynski; Tatjana Brinken; Adrian Mahlmann; Evaldas Girdauskas; Stefan Blankenberg; Yskert von Kodolitsch
Journal:  Cardiovasc Diagn Ther       Date:  2022-08

6.  A SOX17-PDGFB signaling axis regulates aortic root development.

Authors:  Pengfei Lu; Ping Wang; Bingruo Wu; Yidong Wang; Yang Liu; Wei Cheng; Xuhui Feng; Xinchun Yuan; Miriam M Atteya; Haleigh Ferro; Yukiko Sugi; Grant Rydquist; Mahdi Esmaily; Jonathan T Butcher; Ching-Pin Chang; Jack Lenz; Deyou Zheng; Bin Zhou
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.